RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 77 filers reported holding RECRO PHARMA INC in Q3 2018. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $241,000 | +117.1% | 47,990 | +378.0% | 0.07% | +340.0% |
| Q1 2018 | $111,000 | -11.2% | 10,040 | -25.9% | 0.02% | 0.0% |
| Q4 2017 | $125,000 | -0.8% | 13,554 | -3.6% | 0.02% | +7.1% |
| Q3 2017 | $126,000 | -53.2% | 14,054 | -63.3% | 0.01% | -57.6% |
| Q2 2017 | $269,000 | +74.7% | 38,306 | +99.9% | 0.03% | +22.2% |
| Q4 2016 | $154,000 | – | 19,166 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Engine Capital Management, LP | 872,494 | $6,195,000 | 3.64% |
| Newtyn Management, LLC | 1,600,000 | $11,360,000 | 2.22% |
| Broadfin Capital, LLC | 2,048,025 | $14,541,000 | 1.91% |
| Balter Liquid Alternatives, LLC | 92,167 | $654,000 | 0.45% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 515,414 | $3,660,000 | 0.29% |
| JT Stratford LLC | 45,367 | $322,000 | 0.21% |
| Opus Point Partners Management, LLC | 11,353 | $81,000 | 0.18% |
| Alyeska Investment Group, L.P. | 964,000 | $6,844,000 | 0.10% |
| KENNEDY CAPITAL MANAGEMENT LLC | 500,625 | $3,554,000 | 0.09% |
| Monarch Partners Asset Management LLC | 55,857 | $397,000 | 0.06% |